ArticleBiomedicines2024

Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.

Piotr Domański et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.